Osteogenix is a therapeutic products company with novel products for the large and rapidly growing area of bone repair and bone growth. Osteogenix was founded in 2005 to clinically develop and commercialize the osteo-pharmacologic platform discovered and patented by Dr. Mundy and his associates. Osteogenix assembled an outstanding team of expert advisors, many of whom have been principal investigators in key orthobiologics trials.

 

On December 2010, a wholly-owned subsidiary of Medtronic, Inc. acquired substantially all of the assets of Osteogenix, Inc.

 

 

 

532 Emerson Street

Palo Alto, California 94301

info@osteogenix.com

  

A Shalon Ventures Innovation...